Advanced PET Imaging, Nuclear Medicine, and Therapy: From Diagnostics to Theranostics
Friday, May 4, 2018 - Saturday, May 5, 2018
CME Provider:
CME Science › 3790 El Camino Real Suite 2029 Palo Alto, California (CA) 94306 United States
Toll Free: (855) 383-7116 Phone: (650) 440-4424 Fax: (650) 887-2113
Visit the CME Provider Webpage ›
Description:
This course provides a clinical perspective of PET/CT imaging and the emerging use of Theranostic agents within Nuclear Medicine. A broad perspective on the economic, clinical, and academic aspects of the latest trends in PET/CT imaging and Nuclear Medicine therapy will be presented.
At the conclusion of this course, participants will be able to:
• Describe new developments in the merger of diagnostic and therapeutic radioligands for PET/CT imaging and therapy with specific focus on DOTA, PSMA, and PRRT • Describe the logistics of bringing these new diagnostic and therapeutic technologies to clinical practice • Identify the key clinical indications for new emerging tracers for Neuroendocrine Tumor and Prostate cancer using somatostatin receptor and PSMA PET/CT imaging • Review and discuss the standard-of-care clinical application and advanced interpretation of FDG PET/CT
Visit the CME Course Webpage ›
Instructors:
Please visit the CME Science website for more information.
CME Credit:
Physicians: 16 Hours
Radiologic Technologists: Credit Available
Self Assessment Module (SAM):
No
Live Webinar:
Yes
Specialty Audience:
Internal Medicine Radiology
RADLIST Course #17256
|
|
|